| Jan'20 | Oct'19 | Jul'19 | Apr'19 | Jan'19 | Oct'18 | Jul'18 | Apr'18 |
|---|---|---|---|---|---|---|---|
Cash flows from operating activities | |||||||
Net loss | |||||||
-125,656 | -125,670 | -129,114 | -144,338 | -154,309 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization | |||||||
6,917 | 7,342 | 7,841 | 8,266 | 8,787 | 0 | 0 | 0 |
Amortization of contract acquisition costs | |||||||
11,777 | 10,950 | 10,100 | 9,173 | 8,200 | 0 | 0 | 0 |
Stock-based compensation expense | |||||||
23,847 | 22,636 | 21,808 | 27,283 | 21,801 | 0 | 0 | 0 |
Other, net | |||||||
-1,959 | -1,468 | -1,297 | -1,245 | 1,276 | 0 | 0 | 0 |
Change in operating assets and liabilities: | |||||||
Accounts receivable, net | |||||||
-454 | 4,246 | 3,870 | 7,789 | 12,937 | 0 | 0 | 0 |
Contract acquisition costs | |||||||
13,178 | 15,451 | 14,881 | 15,816 | 15,677 | 0 | 0 | 0 |
Prepaid expenses and other | |||||||
1,739 | 3,439 | 5,819 | 9,919 | 4,824 | 0 | 0 | 0 |
Accounts payable | |||||||
-292 | -1,871 | -7,921 | -12,528 | -8,651 | 0 | 0 | 0 |
Accrued expenses and other liabilities | |||||||
-150 | 771 | -358 | 1,875 | 4,605 | 0 | 0 | 0 |
Deferred revenue | |||||||
15,842 | 14,896 | 17,181 | 21,444 | 22,946 | 0 | 0 | 0 |
Net cash used in operating activities | |||||||
-80,219 | -92,643 | -103,806 | -121,158 | -131,367 | 0 | 0 | 0 |
Cash flows from investing activities | |||||||
Purchases of property and equipment | |||||||
6,466 | 6,560 | 6,345 | 6,230 | 6,373 | 0 | 0 | 0 |
Purchases of securities available for sale | |||||||
102,084 | 93,331 | 78,944 | 63,008 | 0 | 0 | 0 | 0 |
Net cash used in investing activities | |||||||
-23,815 | -29,994 | -43,392 | -70,841 | -7,976 | 0 | 0 | 0 |
Cash flows from financing activities | |||||||
Payments of costs related to initial public offering | |||||||
0 | -10 | 640 | 2,742 | 4,053 | 0 | 0 | 0 |
Proceeds from issuance of convertible preferred stock, net of issuance costs | |||||||
0 | -174 | -174 | -174 | -87 | 0 | 0 | 0 |
Proceeds from shares issued in connection with employee stock purchase plan | |||||||
7,812 | 7,812 | 4,518 | 4,518 | 0 | 0 | 0 | 0 |
Shares repurchased for tax withholdings on vesting of restricted stock | |||||||
1,428 | 1,110 | 1,012 | 900 | 0 | 0 | 0 | 0 |
Debt proceeds, net of issuance costs | |||||||
0 | -9 | -9 | -32 | 49,642 | 0 | 0 | 0 |
Proceeds from exercise of stock options | |||||||
1,600 | 3,475 | 3,409 | 3,376 | 2,250 | 0 | 0 | 0 |
Principal payments on capital lease obligations | |||||||
0 | 0 | 0 | 0 | 44 | 0 | 0 | 0 |
Net cash provided by financing activities | |||||||
7,984 | 10,178 | 6,266 | 210,847 | 254,335 | 0 | 0 | 0 |
Effect of exchange rate changes on cash and cash equivalents | |||||||
-80 | -29 | 69 | -21 | 9 | 0 | 0 | 0 |
Net (decrease) increase in cash and cash equivalents | |||||||
-96,130 | -112,488 | -140,863 | 18,827 | 115,001 | 0 | 0 | 0 |
Supplemental disclosures of cash flow information | |||||||
Cash paid for income taxes | |||||||
365 | 334 | 403 | 640 | 822 | 0 | 0 | 0 |
Cash paid for interest | |||||||
9,083 | 9,186 | 9,095 | 8,762 | 6,903 | 0 | 0 | 0 |
Non-cash investing and financing activities | |||||||
Stock-based compensation capitalized as internal-use software | |||||||
480 | 487 | 592 | 660 | 528 | 0 | 0 | 0 |
Debt issuance costs in accounts payable, accrued liabilities and other liabilities, noncurrent | |||||||
- | - | - | 0 | - | - | - | 0 |
Deferred initial public offering costs in accounts payable and accrued liabilities | |||||||
- | - | 0 | 0 | - | - | 0 | 0 |
Issuance of warrants in connection with credit facility | |||||||
0 | 507 | 507 | 507 | 673 | 0 | 0 | 0 |